RxDoctor Payments Data

Melinda Frazee

Family Medicine · Fairmont, WVNPI 1427403807

Payments from drug & device makers

$1,882in general payments, 2019–2025

Across 95 payments — averaging $19.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$606
  • AstraZeneca$419
  • Exact Sciences$199
  • Abbott$166
  • Pfizer$108
  • AbbVie$87
  • plus $297 from 8 others

What the payments were for

  • Food & beverage$1,882100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,882 in reported general payments places this provider in the 75th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$19,736
Medicare patients
50
Services billed
273

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban15$19,738
JanuviaSitagliptin Phosphate19$18,067
MounjaroTirzepatide11$15,323
Albuterol Sulfate HfaAlbuterol Sulfate27$1,007
Atorvastatin Calcium73$603
Duloxetine Hcl19$576
Levothyroxine Sodium38$356
Tizanidine Hcl15$343
Omeprazole39$295
Losartan Potassium30$272
Lisinopril45$247
Ezetimibe14$199
Pantoprazole Sodium23$194
Sertraline Hcl16$152
Rosuvastatin Calcium12$110

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$108$19,73815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Fairmont

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →